Market expert Hemang Jani says "midcap cement companies such as NCL for a 25-30% upside, as the sector could re-rate due to increasing M&A transactions. Also, VIP Industries, which could be acquired by a large luggage company, potentially creating a premium of 20-22%. Jani is positive about the quarterly performance of US generic driven pharma companies, especially Sun Pharma and Dr Reddy's, for medium to long term investment with an 18-20% potential upside.